143 episodes

Small Caps is Australia's #1 site for investor news & information on ASX listed small cap companies.

The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts.

For more information visit: https://smallcaps.com.au/

Small Caps Small Caps

    • Investing
    • 4.9 • 16 Ratings

Small Caps is Australia's #1 site for investor news & information on ASX listed small cap companies.

The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts.

For more information visit: https://smallcaps.com.au/

    Lifespot Health (ASX: LSH) progresses commercialisation of its medical cannabis vape device (w/ Matthew Golden)

    Lifespot Health (ASX: LSH) progresses commercialisation of its medical cannabis vape device (w/ Matthew Golden)

    Lifespot Health (ASX: LSH) chief executive officer Matthew Golden joins Small Caps to discuss the company's cannabis-based medical grade vape devices. Sales of Lifespot's Medihale device have continued to grow and are underpinned by a partnership with ITSUWA and a supply deal with EC Pharma. The company's strategy is to unveil "first to market" medically registered and integrated medical cannabis vape delivery systems.

    • 25 min
    Australia's property bubble and Tony's stock picks for 2021

    Australia's property bubble and Tony's stock picks for 2021

    Tony Locantro, investment manager at Alto Capital, joins Small Caps to share his views on what's taking place in the stock market, where opportunity may lay and what might come next.

    • 37 min
    Kin Mining (ASX: KIN) well-funded to advance drilling at Cardinia gold project (w/ Andrew Munckton)

    Kin Mining (ASX: KIN) well-funded to advance drilling at Cardinia gold project (w/ Andrew Munckton)

    Kin Mining (ASX: KIN) managing director Andrew Munckton joins Small Caps to discuss the company's high-grade exploration results at the Cardinia gold project, with "outstanding" recent assays from the Bruno-Lewis and Cardinia Hill deposits. The next stage of exploration is underpinned by a $12.8 million capital raising during the March quarter. This funding enables Kin to follow-up on other discoveries including the Eagle-Crow prospect, while advancing Bruno-Lewis and Cardinia Hill.

    • 21 min
    Global Energy Ventures (ASX: GEV) powers ahead with innovative compressed hydrogen shipping supply chain solution (w/ Martin Carolan)

    Global Energy Ventures (ASX: GEV) powers ahead with innovative compressed hydrogen shipping supply chain solution (w/ Martin Carolan)

    Global Energy Ventures (ASX: GEV) executive director Martin Carolan joins Small Caps to discuss the company's plans to commercialise its zero-emission, compressed hydrogen marine shipping solution. Mr Carolan noted the company had announced a scoping study at the start of March that showed its compressed hydrogen shipping supply chain was both technically and economically feasible. This was followed up with the American Bureau of Shipping's Approval in Principle being granted later that month for the ship's containment system.

    • 23 min
    K-TIG (ASX: KTG) accelerates expansion plans for 'transformative' keyhole welding technology (w/ Adrian Smith)

    K-TIG (ASX: KTG) accelerates expansion plans for 'transformative' keyhole welding technology (w/ Adrian Smith)

    K-TIG (ASX: KTG) managing director Adrian Smith joins Small Caps to discuss the company's accelerated expansion plans focusing on the US market. During the current quarter, K-TIG expects to secure further US distribution agreements and boost sales in the US through its demonstration site in Pennsylvania. Back in Australia, K-TIG has made inroads into the country's defence sector with two key manufacturing partnerships in recent weeks.

    • 22 min
    Osteopore (ASX: OSX) continues penetrating global markets with breakthrough bone regeneration products (w/ Carl Runde)

    Osteopore (ASX: OSX) continues penetrating global markets with breakthrough bone regeneration products (w/ Carl Runde)

    Osteopore (ASX: OSX) chief financial officer Carl Runde joins Small Caps to discuss the company's breakthrough bioresorbable products which facilitate bone regeneration. The current target markets for Osteopore's products are worth more than US$103 billion. Compared to current procedures, Osteopore's bone regeneration products offer improved patient outcomes while also reducing overall healthcare costs.

    • 24 min

Customer Reviews

4.9 out of 5
16 Ratings

16 Ratings

I.Milat ,

Amanda is great! Big 101.7WSFM fan!

I love Jonesy & Amanda on 101.7WSFM and it’s great to hear Amanda share stock advice under the pseudonym “Kerry Stevenson” on this small caps podcast! Great job Amanda!

mazkal ,

Decent - but Tony is a douche

I like the podcast. But Tony can really come across as an arrogant douche at times.

He’s also a bit of a doomsayer and claims that we’ll see a housing price crash based on very little evidence and grandiose assumptions.

If the host interviewed Tony less frequently, the podcast would be great.

Joey the Don ,

Great podcast!

Great podcast for investors on the ASX. The host’s are great also

Top Podcasts In Investing

Listeners Also Subscribed To